Marinomed Biotech AG (VIE:MARI)
12.15
-0.25 (-2.02%)
May 13, 2025, 5:37 PM CET
Marinomed Biotech AG Revenue
In the year 2024, Marinomed Biotech AG had annual revenue of 4.79M EUR, down -49.01%. Marinomed Biotech AG had revenue of 1.14M in the quarter ending December 31, 2024, a decrease of -51.50%.
Revenue
4.79M
Revenue Growth
-49.01%
P/S Ratio
4.51
Revenue / Employee
122.89K
Employees
52
Market Cap
21.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.79M | -4.61M | -49.01% |
Dec 31, 2023 | 9.40M | -2.34M | -19.96% |
Dec 31, 2022 | 11.74M | 115.90K | 1.00% |
Dec 31, 2021 | 11.63M | 3.50M | 43.12% |
Dec 31, 2020 | 8.12M | 1.38M | 20.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Eurofins Scientific SE | 6.72B |
Tencent Holdings Limited | 82.19B |
Tencent Holdings Limited | 82.19B |
Industrial and Commercial Bank of China Limited | 83.23B |
Hermès International Société en commandite par actions | 14.23B |
Samsung Electronics Co., Ltd. | 199.92B |
Samsung Electronics Co., Ltd. | 199.92B |
China Construction Bank Corporation | 79.11B |